{ "responseHeader":{ "status":0, "QTime":0, "params":{ "q":"iati_identifier:GB-GOV-1-301271", "fl":"*", "format":"json" } }, "response":{ "numFound":1, "start":0, "numFoundExact":true, "docs":[{ "lang":"en", "default_lang":"en", "default-currency":"GBP", "default_currency":"GBP", "hierarchy":1, "iati-identifier":"GB-GOV-1-301271", "iati_identifier":"GB-GOV-1-301271", "reporting-org.ref":"GB-GOV-1", "reporting_org_ref":"GB-GOV-1", "reporting-org.type":"10", "reporting_org_type_code":"10", "reporting-org.narrative":["UK - Foreign, Commonwealth Development Office (FCDO)"], "reporting_org_narrative":["UK - Foreign, Commonwealth Development Office (FCDO)"], "reporting-org.narrative.lang":[" "], "title.narrative":["COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC)"], "title_narrative":["COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC)"], "title_narrative_text":["COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC)"], "title.narrative.lang":[" "], "title_narrative_lang":[" "], "description.type":["1"], "description_type":["1"], "description.narrative":["The UK is supporting early access to COVID-19 vaccines for the world’s poorest countries through a commitment to the COVAX AMC (Advance Market Commitment) using the International Financing Facility for Immunisation (IFFIm). This contribution will support access to at least 1 billion vaccine doses during 2021 for 92 developing countries. This will contribute to ending the acute phase of the COVID-19 pandemic by reducing morbidity and mortality. Supporting access for the world poorest countries demonstrates UK commitment to vaccine multilateralism and supports the UK’s international objectives of bringing the pandemic under control and supporting global economic recovery."], "description_narrative":["The UK is supporting early access to COVID-19 vaccines for the world’s poorest countries through a commitment to the COVAX AMC (Advance Market Commitment) using the International Financing Facility for Immunisation (IFFIm). This contribution will support access to at least 1 billion vaccine doses during 2021 for 92 developing countries. This will contribute to ending the acute phase of the COVID-19 pandemic by reducing morbidity and mortality. Supporting access for the world poorest countries demonstrates UK commitment to vaccine multilateralism and supports the UK’s international objectives of bringing the pandemic under control and supporting global economic recovery."], "description_narrative_text":["The UK is supporting early access to COVID-19 vaccines for the world’s poorest countries through a commitment to the COVAX AMC (Advance Market Commitment) using the International Financing Facility for Immunisation (IFFIm). This contribution will support access to at least 1 billion vaccine doses during 2021 for 92 developing countries. This will contribute to ending the acute phase of the COVID-19 pandemic by reducing morbidity and mortality. Supporting access for the world poorest countries demonstrates UK commitment to vaccine multilateralism and supports the UK’s international objectives of bringing the pandemic under control and supporting global economic recovery."], "description.narrative.lang":[" "], "description_narrative_lang":[" "], "participating-org.ref":["GB-GOV-1","GB-GOV-1","Not available"], "participating_org_ref":["GB-GOV-1","GB-GOV-1","Not available"], "participating-org.type":["10","10"], "participating_org_type":["10","10"], "participating-org.role":["1","2","4","4"], "participating_org_role":["1","2","4","4"], "participating-org.narrative":["Foreign, Commonwealth and Development Office (FCDO)","Foreign, Commonwealth and Development Office (FCDO)","International Finance Facility for Immunisation","International Finance Facility for Immunisation"], "participating_org_narrative":["Foreign, Commonwealth and Development Office (FCDO)","Foreign, Commonwealth and Development Office (FCDO)","International Finance Facility for Immunisation","International Finance Facility for Immunisation"], "participating_org_narrative_text":["Foreign, Commonwealth and Development Office (FCDO)","Foreign, Commonwealth and Development Office (FCDO)","International Finance Facility for Immunisation","International Finance Facility for Immunisation"], "participating-org.narrative.lang":[" "," "," "," "], "participating_org_narrative_lang":[" "," "," "," "], "activity-status.code":"4", "activity_status_code":"4", "activity-date.type":["1","2","3","4"], "activity_date_type":["1","2","3","4"], "activity-date.iso-date":["2021-01-01T00:00:00Z","2021-01-11T00:00:00Z","2030-03-31T00:00:00Z","2024-07-30T00:00:00Z"], "activity_date_iso_date":["2021-01-01T00:00:00Z","2021-01-11T00:00:00Z","2030-03-31T00:00:00Z","2024-07-30T00:00:00Z"], "contact-info.type":["1"], "contact_info_type":["1"], "contact-info.organisation.narrative":["UK - Foreign, Commonwealth Development Office (FCDO)"], "contact_info_organisation_narrative":["UK - Foreign, Commonwealth Development Office (FCDO)"], "contact_info_organisation_narrative_text":["UK - Foreign, Commonwealth Development Office (FCDO)"], "contact-info.organisation.narrative.lang":[" "], "contact_info_organisation_narrative_lang":[" "], "contact-info.telephone":["+44 (0) 1355 84 3132"], "contact_info_telephone":["+44 (0) 1355 84 3132"], "contact-info.email":["enquiry@fcdo.gov.uk"], "contact_info_email":["enquiry@fcdo.gov.uk"], "contact-info.mailing-address.narrative":["Public Enquiry Point, Abercrombie House, Eaglesham Road, East Kilbride, Glasgow G75 8EA"], "contact_info_mailing_address_narrative":["Public Enquiry Point, Abercrombie House, Eaglesham Road, East Kilbride, Glasgow G75 8EA"], "contact_info_mailing_address_narrative_text":["Public Enquiry Point, Abercrombie House, Eaglesham Road, East Kilbride, Glasgow G75 8EA"], "contact-info.mailing-address.narrative.lang":[" "], "contact_info_mailing_address_narrative_lang":[" "], "activity-scope.code":"3", "activity_scope_code":"3", "recipient-region.code":["998"], "recipient_region_code":["998"], "recipient-region.percentage":[100.0], "recipient_region_percentage":[100.0], "sector.vocabulary":["1"], "sector_vocabulary":["1"], "sector.vocabulary-uri":["http://reference.iatistandard.org/codelists/Sector/"], "sector_vocabulary_uri":["http://reference.iatistandard.org/codelists/Sector/"], "sector.code":["99810"], "sector_code":["99810"], "sector.percentage":[100.0], "sector_percentage":[100.0], "sector.narrative":["Sectors not specified"], "sector_narrative":["Sectors not specified"], "sector_narrative_text":["Sectors not specified"], "sector.narrative.lang":[" "], "sector_narrative_lang":[" "], "policy-marker.vocabulary":["1","1","1","1","1","1"], "policy_marker_vocabulary":["1","1","1","1","1","1"], "policy-marker.code":["1","5","6","7","8","11"], "policy_marker_code":["1","5","6","7","8","11"], "policy-marker.significance":["1","0","0","0","0","0"], "policy_marker_significance":["1","0","0","0","0","0"], "policy-marker.narrative":["Gender Equality","Aid Targeting the Objectives of the Convention on Biological Diversity","Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation","Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation","Aid Targeting the Objectives of the Convention to Combat Desertification","Disability"], "policy_marker_narrative":["Gender Equality","Aid Targeting the Objectives of the Convention on Biological Diversity","Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation","Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation","Aid Targeting the Objectives of the Convention to Combat Desertification","Disability"], "policy_marker_narrative_text":["Gender Equality","Aid Targeting the Objectives of the Convention on Biological Diversity","Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation","Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation","Aid Targeting the Objectives of the Convention to Combat Desertification","Disability"], "policy-marker.narrative.lang":[" "," "," "," "," "," "], "policy_marker_narrative_lang":[" "," "," "," "," "," "], "default-tied-status.code":"5", "default_tied_status_code":"5", "document-link.url":["http://iati.fcdo.gov.uk/iati_documents/D0005526.odt","http://iati.fcdo.gov.uk/iati_documents/D0005626.odt","http://iati.fcdo.gov.uk/iati_documents/D0003796.odt","http://iati.fcdo.gov.uk/iati_documents/D0000845.odt","http://iati.fcdo.gov.uk/iati_documents/90000973.xlsx","http://iati.fcdo.gov.uk/iati_documents/61254722.odt"], "document_link_url":["http://iati.fcdo.gov.uk/iati_documents/D0005526.odt","http://iati.fcdo.gov.uk/iati_documents/D0005626.odt","http://iati.fcdo.gov.uk/iati_documents/D0003796.odt","http://iati.fcdo.gov.uk/iati_documents/D0000845.odt","http://iati.fcdo.gov.uk/iati_documents/90000973.xlsx","http://iati.fcdo.gov.uk/iati_documents/61254722.odt"], "document-link.format":["application/vnd.oasis.opendocument.text","application/vnd.oasis.opendocument.text","application/vnd.oasis.opendocument.text","application/vnd.oasis.opendocument.text","application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","application/vnd.oasis.opendocument.text"], "document_link_format":["application/vnd.oasis.opendocument.text","application/vnd.oasis.opendocument.text","application/vnd.oasis.opendocument.text","application/vnd.oasis.opendocument.text","application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","application/vnd.oasis.opendocument.text"], "document-link.title.narrative":["Addendum to the Business Case (D0005526) 301271 (Published - August 2024)","Project completion review (D0005626) 301271 (Published - August 2024)","Annual review (D0003796) 301271 (Published - November 2023)","Annual review (D0000845) 301271 (Published - June 2022)","Logical Framework (90000973) 301271 (Published - May 2022)","Business Case and Summary (61254722) 301271 (Published - June 2021)"], "document_link_title_narrative":["Addendum to the Business Case (D0005526) 301271 (Published - August 2024)","Project completion review (D0005626) 301271 (Published - August 2024)","Annual review (D0003796) 301271 (Published - November 2023)","Annual review (D0000845) 301271 (Published - June 2022)","Logical Framework (90000973) 301271 (Published - May 2022)","Business Case and Summary (61254722) 301271 (Published - June 2021)"], "document_link_title_narrative_text":["Addendum to the Business Case (D0005526) 301271 (Published - August 2024)","Project completion review (D0005626) 301271 (Published - August 2024)","Annual review (D0003796) 301271 (Published - November 2023)","Annual review (D0000845) 301271 (Published - June 2022)","Logical Framework (90000973) 301271 (Published - May 2022)","Business Case and Summary (61254722) 301271 (Published - June 2021)"], "document-link.title.narrative.lang":[" "," "," "," "," "," "], "document_link_title_narrative_lang":[" "," "," "," "," "," "], "document-link.category.code":["A02","A03","A04","A05","A01","A07","A08","A07","A08","A07","A08","A02","A08","A01","A02","A03","A04","A05"], "document_link_category_code":["A02","A03","A04","A05","A01","A07","A08","A07","A08","A07","A08","A02","A08","A01","A02","A03","A04","A05"], "document-link.language.code":["en","en","en","en","en","en"], "document_link_language_code":["en","en","en","en","en","en"], "document-link.document-date.iso-date":["2024-08-26T00:00:00Z","2024-08-26T00:00:00Z","2023-11-28T00:00:00Z","2022-06-14T00:00:00Z","2022-05-16T00:00:00Z","2021-06-04T00:00:00Z"], "document_link_document_date_iso_date":["2024-08-26T00:00:00Z","2024-08-26T00:00:00Z","2023-11-28T00:00:00Z","2022-06-14T00:00:00Z","2022-05-16T00:00:00Z","2021-06-04T00:00:00Z"], "related-activity.ref":["GB-GOV-1-301271-101","GB-GOV-1-301271-401"], "related_activity_ref":["GB-GOV-1-301271-101","GB-GOV-1-301271-401"], "related-activity.type":["2","2"], "related_activity_type":["2","2"], "reporting-org.type.name":"Government", "reporting_org_type_name":"Government", "recipient-region.name":["Developing countries, unspecified"], "recipient_region_name":["Developing countries, unspecified"], "policy-marker.name":["Gender Equality","Aid Targeting the Objectives of the Convention on Biological Diversity","Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation","Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation","Aid Targeting the Objectives of the Convention to Combat Desertification","Disability"], "policy-marker.significance.name":["significant objective","not targeted","not targeted","not targeted","not targeted","not targeted"], "policy-marker.vocabulary.name":["OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS"], "title.narrative.first":"COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC)", "title_narrative_first":"COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC)", "activity-date.start-planned":"2021-01-01T00:00:00Z", "activity_date_start_planned":"Fri Jan 01 00:00:00 UTC 2021", "activity_date_start_planned_f":"2021-01-01T00:00:00Z", "activity-date.common.start":"2021-01-11T00:00:00Z", "activity_date_start_common":"Mon Jan 11 00:00:00 UTC 2021", "activity_date_start_common_f":"2021-01-11T00:00:00Z", "activity-date.start-actual":"2021-01-11T00:00:00Z", "activity_date_start_actual":"Mon Jan 11 00:00:00 UTC 2021", "activity_date_start_actual_f":"2021-01-11T00:00:00Z", "activity-date.end-planned":"2030-03-31T00:00:00Z", "activity_date_end_planned":"Sun Mar 31 00:00:00 UTC 2030", "activity_date_end_planned_f":"2030-03-31T00:00:00Z", "activity-date.common.end":"2024-07-30T00:00:00Z", "activity_date_end_common":"Tue Jul 30 00:00:00 UTC 2024", "activity_date_end_common_f":"2024-07-30T00:00:00Z", "activity-date.end-actual":"2024-07-30T00:00:00Z", "activity_date_end_actual":"Tue Jul 30 00:00:00 UTC 2024", "activity_date_end_actual_f":"2024-07-30T00:00:00Z", "activity-status.text":"Closed", "activity_status_text":"Closed", "policy-marker.combined":["1__1","5__0","6__0","7__0","8__0","11__0"], "policy_marker_combined":["1__1","5__0","6__0","7__0","8__0","11__0"], "dataset.id":"4841c06f-0067-4269-b9c0-ebc08dff2e8e", "dataset_iati_id":"4841c06f-0067-4269-b9c0-ebc08dff2e8e", "dataset.name":"fcdo-set-19", "dataset_name":"fcdo-set-19", "dataset.extras.iati_version":"2.03", "dataset.resources.hash":"4238b6167986f89ef909537206ee84ce887fe0dc", "dataset.resources.url":"http://iati.fcdo.gov.uk/iati_files/solr/FCDO-set-19.xml", "activity-date.quarter":[1,1,1,3], "document-link.document-date.quarter":[3,3,4,2,2,2], "document-link.category-codes-combined":["A02,A03,A04,A05","A01,A07,A08","A07,A08","A07,A08","A02,A08","A01,A02,A03,A04,A05"], "child-aggregation.budget.value":1.8E8, "child_aggregation_budget_value":1.8E8, "activity-plus-child-aggregation.budget.value":1.8E8, "activity_plus_child_aggregation_budget_value":1.8E8, "child-aggregation.budget.currency":"USD", "child_aggregation_budget_currency":"USD", "activity-plus-child-aggregation.budget.currency":"USD", "activity_plus_child_aggregation_budget_currency":"USD", "child-aggregation.budget.value-usd":2.3882721478612638E8, "child_aggregation_budget_value_usd":2.3882721478612638E8, "activity-plus-child-aggregation.budget.value-usd":2.3882721478612638E8, "activity_plus_child_aggregation_budget_value_usd":2.3882721478612638E8, "child-aggregation.budget.value-gbp":1.8E8, "child_aggregation_budget_value_gbp":1.8E8, "activity-plus-child-aggregation.budget.value-gbp":1.8E8, "activity_plus_child_aggregation_budget_value_gbp":1.8E8, "child-aggregation.outgoing-commitment.value":1.8E8, "child_aggregation_commitment_value":1.8E8, "activity-plus-child-aggregation.outgoing-commitment.value":1.8E8, "activity_plus_child_aggregation_commitment_value":1.8E8, "child-aggregation.outgoing-commitment.currency":"USD", "child_aggregation_commitment_currency":"USD", "activity-plus-child-aggregation.outgoing-commitment.currency":"USD", "activity_plus_child_aggregation_commitment_currency":"USD", "child-aggregation.outgoing-commitment.value-usd":2.1460535033342052E8, "child_aggregation_commitment_value_usd":2.1460535033342052E8, "activity-plus-child-aggregation.outgoing-commitment.value-usd":2.1460535033342052E8, "activity_plus_child_aggregation_commitment_value_usd":2.1460535033342052E8, "child-aggregation.outgoing-commitment.value-gbp":1.8E8, "child_aggregation_commitment_value_gbp":1.8E8, "activity-plus-child-aggregation.outgoing-commitment.value-gbp":1.8E8, "activity_plus_child_aggregation_commitment_value_gbp":1.8E8, "child-aggregation.disbursement.value":1.8E8, "child_aggregation_disbursement_value":1.8E8, "activity-plus-child-aggregation.disbursement.value":1.8E8, "activity_plus_child_aggregation_disbursement_value":1.8E8, "child-aggregation.disbursement.currency":"USD", "child_aggregation_disbursement_currency":"USD", "activity-plus-child-aggregation.disbursement.currency":"USD", "activity_plus_child_aggregation_disbursement_currency":"USD", "child-aggregation.disbursement.value-usd":2.1019191625960505E8, "child_aggregation_disbursement_value_usd":2.1019191625960505E8, "activity-plus-child-aggregation.disbursement.value-usd":2.1019191625960505E8, "activity_plus_child_aggregation_disbursement_value_usd":2.1019191625960505E8, "child-aggregation.disbursement.value-gbp":1.8E8, "child_aggregation_disbursement_value_gbp":1.8E8, "activity-plus-child-aggregation.disbursement.value-gbp":1.8E8, "activity_plus_child_aggregation_disbursement_value_gbp":1.8E8, "json.reporting-org":"{\"ref\": \"GB-GOV-1\", \"type\": 10, \"narrative\": \"UK - Foreign, Commonwealth Development Office (FCDO)\", \"narrative.lang\": \" \"}", "json.title":"{\"narrative\": \"COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC)\", \"narrative.lang\": \" \"}", "json.description":["{\"type\": 1, \"narrative\": \"The UK is supporting early access to COVID-19 vaccines for the world\\u2019s poorest countries through a commitment to the COVAX AMC (Advance Market Commitment) using the International Financing Facility for Immunisation (IFFIm). This contribution will support access to at least 1 billion vaccine doses during 2021 for 92 developing countries. This will contribute to ending the acute phase of the COVID-19 pandemic by reducing morbidity and mortality. Supporting access for the world poorest countries demonstrates UK commitment to vaccine multilateralism and supports the UK\\u2019s international objectives of bringing the pandemic under control and supporting global economic recovery.\", \"narrative.lang\": \" \"}"], "json.participating-org":["{\"ref\": \"GB-GOV-1\", \"type\": 10, \"role\": 1, \"narrative\": \"Foreign, Commonwealth and Development Office (FCDO)\", \"narrative.lang\": \" \"}","{\"ref\": \"GB-GOV-1\", \"type\": 10, \"role\": 2, \"narrative\": \"Foreign, Commonwealth and Development Office (FCDO)\", \"narrative.lang\": \" \"}","{\"role\": 4, \"narrative\": \"International Finance Facility for Immunisation\", \"narrative.lang\": \" \"}","{\"ref\": \"Not available\", \"role\": 4, \"narrative\": \"International Finance Facility for Immunisation\", \"narrative.lang\": \" \"}"], "json.activity-date":["{\"type\": 1, \"iso-date\": \"2021-01-01\"}","{\"type\": 2, \"iso-date\": \"2021-01-11\"}","{\"type\": 3, \"iso-date\": \"2030-03-31\"}","{\"type\": 4, \"iso-date\": \"2024-07-30\"}"], "json.contact-info":["{\"type\": 1, \"organisation\": {\"narrative\": \"UK - Foreign, Commonwealth Development Office (FCDO)\", \"narrative.lang\": \" \"}, \"telephone\": \"+44 (0) 1355 84 3132\", \"email\": \"enquiry@fcdo.gov.uk\", \"mailing-address\": {\"narrative\": \"Public Enquiry Point, Abercrombie House, Eaglesham Road, East Kilbride, Glasgow G75 8EA\", \"narrative.lang\": \" \"}}"], "json.recipient-region":["{\"code\": 998, \"percentage\": 100.0}"], "json.sector":["{\"vocabulary\": 1, \"vocabulary-uri\": \"http://reference.iatistandard.org/codelists/Sector/\", \"code\": 99810, \"percentage\": 100.0, \"narrative\": \"Sectors not specified\", \"narrative.lang\": \" \"}"], "json.policy-marker":["{\"vocabulary\": 1, \"code\": 1, \"significance\": 1, \"narrative\": \"Gender Equality\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 5, \"significance\": 0, \"narrative\": \"Aid Targeting the Objectives of the Convention on Biological Diversity\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 6, \"significance\": 0, \"narrative\": \"Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 7, \"significance\": 0, \"narrative\": \"Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 8, \"significance\": 0, \"narrative\": \"Aid Targeting the Objectives of the Convention to Combat Desertification\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 11, \"significance\": 0, \"narrative\": \"Disability\", \"narrative.lang\": \" \"}"], "json.document-link":["{\"url\": \"http://iati.fcdo.gov.uk/iati_documents/D0005526.odt\", \"format\": \"application/vnd.oasis.opendocument.text\", \"title\": {\"narrative\": \"Addendum to the Business Case (D0005526) 301271 (Published - August 2024)\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A02\"}, {\"code\": \"A03\"}, {\"code\": \"A04\"}, {\"code\": \"A05\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-08-26\"}]}","{\"url\": \"http://iati.fcdo.gov.uk/iati_documents/D0005626.odt\", \"format\": \"application/vnd.oasis.opendocument.text\", \"title\": {\"narrative\": \"Project completion review (D0005626) 301271 (Published - August 2024)\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A01\"}, {\"code\": \"A07\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-08-26\"}]}","{\"url\": \"http://iati.fcdo.gov.uk/iati_documents/D0003796.odt\", \"format\": \"application/vnd.oasis.opendocument.text\", \"title\": {\"narrative\": \"Annual review (D0003796) 301271 (Published - November 2023)\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2023-11-28\"}]}","{\"url\": \"http://iati.fcdo.gov.uk/iati_documents/D0000845.odt\", \"format\": \"application/vnd.oasis.opendocument.text\", \"title\": {\"narrative\": \"Annual review (D0000845) 301271 (Published - June 2022)\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2022-06-14\"}]}","{\"url\": \"http://iati.fcdo.gov.uk/iati_documents/90000973.xlsx\", \"format\": \"application/vnd.openxmlformats-officedocument.spreadsheetml.sheet\", \"title\": {\"narrative\": \"Logical Framework (90000973) 301271 (Published - May 2022)\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A02\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2022-05-16\"}]}","{\"url\": \"http://iati.fcdo.gov.uk/iati_documents/61254722.odt\", \"format\": \"application/vnd.oasis.opendocument.text\", \"title\": {\"narrative\": \"Business Case and Summary (61254722) 301271 (Published - June 2021)\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A01\"}, {\"code\": \"A02\"}, {\"code\": \"A03\"}, {\"code\": \"A04\"}, {\"code\": \"A05\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2021-06-04\"}]}"], "json.related-activity":["{\"ref\": \"GB-GOV-1-301271-101\", \"type\": 2}","{\"ref\": \"GB-GOV-1-301271-401\", \"type\": 2}"], "related_budget_value":[100000000,80000000], "related_budget_period_start_quarter":[4,4], "related_budget_period_end_quarter":[4,4], "related_budget_period_start_iso_date":["2022-10-01T00:00:00Z","2023-10-01T00:00:00Z"], "related_budget_period_end_iso_date":["2022-12-31T00:00:00Z","2023-12-31T00:00:00Z"], "related_activity_context":"ID: GB-GOV-1-301271\nTitle: COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC)\nDescription: The UK is supporting early access to COVID-19 vaccines for the world’s poorest countries through a commitment to the COVAX AMC (Advance Market Commitment) using the International Financing Facility for Immunisation (IFFIm). This contribution will support access to at least 1 billion vaccine doses during 2021 for 92 developing countries. This will contribute to ending the acute phase of the COVID-19 pandemic by reducing morbidity and mortality. Supporting access for the world poorest countries demonstrates UK commitment to vaccine multilateralism and supports the UK’s international objectives of bringing the pandemic under control and supporting global economic recovery.\n \n ID: GB-GOV-1-301271-101\nTitle: COVID-19 vaccine funding for the COVAX Advance Market Commitment\nDescription: Provide COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC), enabling it to supply safe and effective COVID-19 vaccine doses to 92 Overseas Development Assistance (ODA) eligible countries to vaccinate their high populations and help end the acute phase of the pandemic\n \n ID: GB-GOV-1-301271-401\nTitle: COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC) programme\nDescription: To provide COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC) programme, enabling it to supply safe and effective COVID-19 vaccine doses to 92 Overseas Development Assistance (ODA) eligible countries to vaccinate their high populations and help end the acute phase of the pandemic\n", "id":"fd756888-e4a0-4021-b053-27197fa8ccea", "_version_":1866240363905155072 }] } }